APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome

Neurology

Volumn 53, Issue 2, 1999, Pages 331-336

  Lai, Florence ^a,b,c,e   Kammann, E ^c,d   Rebeck, G W ^b,c   Anderson, A ^a,b   Chen, Y ^a,b   Nixon, R A ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DOWN SYNDROME; GENDER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033595202     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.2.331     Document Type: Article

References (37)

1. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-282.
2. Prasher VP, Farrer MJ, Kessling AM, et al. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol 1998;43:380-383.
3. Lai F. Clinicopathologic features of Alzheimer disease in Down syndrome. Prog Clin Biol Res 1992;379:15-34.
4. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-853.
5. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
6. van Gool WA, Evenhuis HM, van Duijn CM. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. Ann Neurol 1995;38:225-230.
7. Schupf N, Kapell D, Lee JH, et al. Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome. Ann Neurol 1996;40:799-801.
8. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
9. Royston MC, Mann D, Pickering-Brown S, et al. Apolipoprotein E ε2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 1994;5: 2583-2585.
10. Albert M, Cohen C. The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 1992;40:449-453.
11. McCarthy D. Manual for the McCarthy Scales of Children's Abilities. San Antonio, TX: The Psychological Corporation, 1972.
12. Evenhuis HM, Kengen MMG, Eurlings HAL. Dementia Questionnaire for Mentally Retarded Persons. Swannerdam, The Netherlands: Hooge Burch Institute for Mentally Retarded People, 1990.
13. The ICD-10 Classification of Mental and Behavioral Disorders: diagnostic criteria for research. Geneva, Switzerland: World Health Organization, 1993.
14. Aylward EH, Burt B, Thorpe LU, Lai F, Dalton AJ. Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 1997;41:152-164.
15. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
16. Zung WWK. The Depression Status Inventory: an adjunct to the Self-Rating Depression Scale. J Clin Psychol 1972;28: 539-543.
17. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.
18. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 1996;19:53-77.
19. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
20. Holder JL, Habbak RA, Pearlson GD, Aylward EA, Pulsifer M, Warren AC. Reduced survival of APOE4 homozygotes in Down's syndrome? Neuroreport 1996;7:2455-2456.
21. Edland SD, Wijsman EM, Schoder-Ehri GL, Leverenz JB. Little evidence of reduced survival to adulthood of APOE epsilon4 homozygotes in Down's syndrome. Neuroreport 1997;8: 3463-3465.
22. Lambert J-C, Pérez-Tur J, Dupire M-J, Delacourte A, Frigard B, Chartier-Harlin M-C. Analysis of the APOE alleles impact in Down's syndrome. Neurosci Lett 1996;220:57-60.
23. Tyrrell J, Cosgrave M, Hawi Z, et al. A protective effect of apolipoprotein E ε2 allele on dementia in Down's syndrome. Biol Psychiatry 1998;43:397-400.
24. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-1247.
25. Benjamin R, Leake A, McArthur FK, et al. Protective effect of apoE ε2 in Alzheimer's disease. Lancet 1994;344:473. Letter.
26. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD. Apolipoprotein E-ε2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 1997;48: 515-519.
27. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
28. Levy-Lahad E, Lahad A, Wijsman EM, Bird TD, Schellenberg GD. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995;38: 678-680.
29. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778.
30. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer disease. Nature 1995;375:754-760.
31. von Broeckhoven C. Molecular genetics of Alzheimer's disease: identification of genes and gene mutations. Eur Neurol 1995; 35:8-19.
32. Meyer MR, Tschanz JT, Norten MC, et al. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat Genet 1998;19:321-322.
33. Prasher VP, Chowdhury TA, Rowe BR, Bain SC. APOE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis. Am J Ment Retard 1997;102:103-110.
34. Schupf N, Kapell D, Nightingale B, Rodriguez A, Tycko B, Mayeux R. Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology 1998;50:991-995.
35. Amaducci L, Falcini M, Lippa A. Descriptive epidemiology and risk factors for Alzheimer disease. Acta Neurol Scand Suppl 1992;139:21-25.
36. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994;29:431-436.
37. Xu H, Gouras GK, Greenfield JP, et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 1998;4:447-451.